320 related articles for article (PubMed ID: 12673717)
21. Recombinant adeno-associated virus mediated RNA interference inhibits metastasis of nasopharyngeal cancer cells in vivo and in vitro by suppression of Epstein-Barr virus encoded LMP-1.
Li X; Liu X; Li CY; Ding Y; Chau D; Li G; Kung HF; Lin MC; Peng Y
Int J Oncol; 2006 Sep; 29(3):595-603. PubMed ID: 16865275
[TBL] [Abstract][Full Text] [Related]
22. Epstein-Barr virus latent membrane protein 1 (EBV-LMP1) and tumor proliferation rate as predictive factors of nasopharyngeal cancer (NPC) radiation response.
Gondhowiardjo S
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():323-31. PubMed ID: 10895175
[TBL] [Abstract][Full Text] [Related]
23. Complementary serum test of antibodies to Epstein-Barr virus nuclear antigen-1 and early antigen: a possible alternative for primary screening of nasopharyngeal carcinoma.
Chang KP; Hsu CL; Chang YL; Tsang NM; Chen CK; Lee TJ; Tsao KC; Huang CG; Chang YS; Yu JS; Hao SP
Oral Oncol; 2008 Aug; 44(8):784-92. PubMed ID: 18206420
[TBL] [Abstract][Full Text] [Related]
24. [Quantitative analysis of Epstein-Barr virus DNA in plasma and peripheral blood cells in patients with nasopharyngeal carcinoma].
Zhang Y; Gao HY; Feng HX; Deng L; Huang MY; Hu B; Cheng G; Wu QL; Cui NJ; Shao JY
Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(12):982-6. PubMed ID: 15312530
[TBL] [Abstract][Full Text] [Related]
25. [Real-time quantitative PCR assay of Epstein-Barr virus in whole blood cells of nasopharyngeal carcinoma patients].
Wang H; Deng L; Chen SH; Wang SQ; Cao Y
Shi Yan Sheng Wu Xue Bao; 2003 Feb; 36(1):32-6. PubMed ID: 12751207
[TBL] [Abstract][Full Text] [Related]
26. Polymerase chain reaction study of Epstein-Barr virus in high risk group of nasopharyngeal carcinoma: a preliminary report.
Luxamechanporn T; Neimhom S; Kunachak S; Kulapaditharom B
J Med Assoc Thai; 1999 Jun; 82(6):593-7. PubMed ID: 10443082
[TBL] [Abstract][Full Text] [Related]
27. [Latency of Epstein-Barr virus and its relationship to nasopharyngeal carcinomas].
You S; Yao K; Cao Y
Zhonghua Zhong Liu Za Zhi; 1996 Jan; 18(1):23-6. PubMed ID: 8732106
[TBL] [Abstract][Full Text] [Related]
28. Expression of syndecan-1 (CD138) in nasopharyngeal carcinoma is correlated with advanced stage and poor prognosis.
Chen CL; Ou DL
Hum Pathol; 2006 Oct; 37(10):1279-85. PubMed ID: 16949936
[TBL] [Abstract][Full Text] [Related]
29. Detection of Epstein-Barr virus DNA in plasma/serum: a useful serological indicator for diagnosis of nasopharyngeal carcinoma.
Mai S; Zong Y; Zhang M; Zhong B; Lin S
Chin Med J (Engl); 2002 Dec; 115(12):1895-7. PubMed ID: 12622949
[TBL] [Abstract][Full Text] [Related]
30. [Detection of Epstein-Barr virus DNA in desquamative cell of nasopharyngeal carcinoma by polymerase chain reaction].
Chen W; Chen Y; Ji C
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1994; 29(6):327-9. PubMed ID: 7742020
[TBL] [Abstract][Full Text] [Related]
31. Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma.
Shao JY; Li YH; Gao HY; Wu QL; Cui NJ; Zhang L; Cheng G; Hu LF; Ernberg I; Zeng YX
Cancer; 2004 Mar; 100(6):1162-70. PubMed ID: 15022282
[TBL] [Abstract][Full Text] [Related]
32. [Sequence analysis of the CTL epitopes in transmembrane region of latent membrane protein 2 of Epstein-Barr virus derived from nasopharyngeal carcinoma cells].
Zhang NH; Zhang XS; Li J; Zhang RH; Gao YF; Zeng MS
Ai Zheng; 2006 May; 25(5):566-9. PubMed ID: 16687075
[TBL] [Abstract][Full Text] [Related]
33. [Application of EB virus latent membrane protein 1 in nasopharyngeal swab in diagnosis of nasopharyngeal carcinoma].
Xie Y; Huang G; Zhang Z; Wen W; Wu Y; Wei Z
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2006 Jun; 20(11):499-501. PubMed ID: 16929830
[TBL] [Abstract][Full Text] [Related]
34. Epstein-Barr virus DNA in serum/plasma as a tumor marker for nasopharyngeal cancer.
Shotelersuk K; Khorprasert C; Sakdikul S; Pornthanakasem W; Voravud N; Mutirangura A
Clin Cancer Res; 2000 Mar; 6(3):1046-51. PubMed ID: 10741733
[TBL] [Abstract][Full Text] [Related]
35. Epstein-Barr virus (EBV) latent membrane protein 1 induces interleukin-8 through the nuclear factor-kappa B signaling pathway in EBV-infected nasopharyngeal carcinoma cell line.
Ren Q; Sato H; Murono S; Furukawa M; Yoshizaki T
Laryngoscope; 2004 May; 114(5):855-9. PubMed ID: 15126743
[TBL] [Abstract][Full Text] [Related]
36. Analyses of Epstein-Barr virus latent membrane protein-1 in Malaysian nasopharyngeal carcinoma: high prevalence of 30-bp deletion, Xho1 polymorphism and evidence of dual infections.
Tan EL; Peh SC; Sam CK
J Med Virol; 2003 Feb; 69(2):251-7. PubMed ID: 12683415
[TBL] [Abstract][Full Text] [Related]
37. Nasopharyngeal carcinoma in Indonesia has a low prevalence of the 30-base pair deletion of Epstein-Barr virus latent membrane protein 1.
Nurhantari Y; Emoto N; Rahayu P; Matsuo M
Southeast Asian J Trop Med Public Health; 2003 Mar; 34(1):98-105. PubMed ID: 12971521
[TBL] [Abstract][Full Text] [Related]
38. Epstein-Barr virus DNA in nasopharyngeal carcinoma in Thai patients at Ramathibodi Hospital, Bangkok.
Niemhom S; Maeda S; Raksakait K; Petchclai B
Southeast Asian J Trop Med Public Health; 1995; 26 Suppl 1():325-8. PubMed ID: 8629135
[TBL] [Abstract][Full Text] [Related]
39. The time frame of Epstein-Barr virus latent membrane protein-1 gene to disappear in nasopharyngeal swabs after initiation of primary radiotherapy is an independently significant prognostic factor predicting local control for patients with nasopharyngeal carcinoma.
Lin SY; Chang KP; Hsieh MS; Ueng SH; Hao SP; Tseng CK; Pai PC; Chang FT; Tsai MH; Tsang NM
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1339-46. PubMed ID: 16169672
[TBL] [Abstract][Full Text] [Related]
40. Epstein-Barr virus DNA detection in the diagnosis of nasopharyngeal carcinoma.
Yap YY; Hassan S; Chan M; Choo PK; Ravichandran M
Otolaryngol Head Neck Surg; 2007 Jun; 136(6):986-91. PubMed ID: 17547993
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
